Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen delivery
Qianyuan
He
a,
Zhanjie
Zhang
a,
Haojie
Liu
b,
Zhan
Tuo
a,
Jie
Zhou
a,
Yan
Hu
a,
Yajie
Sun
a,
Chao
Wan
a,
Zushun
Xu
b,
Jonathan F.
Lovell
c,
Desheng
Hu
*d,
Kunyu
Yang
*a and
Honglin
Jin
*a
aCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. E-mail: jin@hust.edu.cn; yangkunyu@medmail.com.cn
bHubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Ministry of Education Key Laboratory for the Green Preparation and Application of Functional Materials, Hubei Key Laboratory of Polymer Materials, Hubei University, Wuhan, Hubei 430062, China
cDepartment of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York 14260, USA
dDepartment of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. E-mail: desheng.hu@hust.edu.cn
First published on 3rd January 2025
Abstract
Correction for ‘Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen delivery’ by Qianyuan He et al., Nanoscale, 2020, 12, 14788–14800, https://doi.org/10.1039/D0NR02750B.
The authors regret that an incorrect version of Fig. 4D was included in the originally published article. The correct version of Fig. 4 is shown below.
 | ||
| Fig. 4 In vivo evaluation of SCM@BSA anti-tumor effects and distribution. (A) Therapeutic mechanism of SCM@BSA in the tumor site. (B) Body weight versus time after various treatments of the different groups (n = 5). (C) Relative tumor volume of the different groups after different treatments (n = 5). (D) Photographs of tumor-bearing mice at different times after different treatments. (E) Mn2+ biodistribution in the main organs 24 h after treatment. (F) Mn2+ biodistribution in the blood versus time. (G) Quantitative CD31 immunohistochemical assay of each group (n = 5). Data are presented as the mean ± SEM (E, F: n = 3). | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |